Significant Ownership of Panacea Innovation Ltd

Signature - Title
/s/ James Huang - James Huang, Founding Managing Partner
Location
Grand Cayman, Cayman Islands
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Panacea Innovation Ltd.

Notify me when Panacea Innovation Ltd files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Panacea Innovation Ltd

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CNTB Connect Biopharma Holdings Limited Ordinary Shares 25.1% $13,950,000 13,950,000 Panacea Innovation Limited 21 Jul 2025
CASI CASI Pharmaceuticals, Inc. Ordinary Shares 22.5% $4,698,042 $999,855 4,651,527 +27% James Huang 16 Dec 2025
CNTB Connect Biopharma Holdings Limited Ordinary Shares 21.5% $21,840,000 12,000,000 Panacea Innovation Limited 24 Nov 2025
ATRA Atara Biotherapeutics, Inc. Common Stock 20% 1,712,900 +4.5% Panacea Innovation Limited 15 Aug 2025
ATRA Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share 9.5% $4,180,000 550,000 Panacea Venture Healthcare Fund II, L.P. 30 Jan 2025
ADAG Adagene Inc. Ordinary Shares 3.8% $4,469,175 -$1,564,211 2,250,000 -25.9% Panacea Venture Healthcare Fund II, L.P. 30 Sep 2025
AMLX Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 2.6% $11,792,000 2,200,000 Panacea Venture Healthcare Fund II, L.P. 31 Dec 2024
MRNS Marinus Pharmaceuticals, Inc. Common Stock 0% $0 0 Panacea Venture Healthcare Fund II, L.P. 31 Dec 2024

Schedules 13D/G Reported by Panacea Innovation Ltd:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.